4887 Stock Overview
Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Sawai Group Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,151.00 |
| 52 Week High | JP¥2,308.67 |
| 52 Week Low | JP¥1,701.33 |
| Beta | 0.17 |
| 1 Month Change | -1.08% |
| 3 Month Change | 3.91% |
| 1 Year Change | 23.88% |
| 3 Year Change | 46.83% |
| 5 Year Change | -6.34% |
| Change since IPO | 313.65% |
Recent News & Updates
Here's Why Sawai Group Holdings (TSE:4887) Has Caught The Eye Of Investors
Dec 20
Here's Why Sawai Group Holdings (TSE:4887) Has A Meaningful Debt Burden
Nov 30Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?
Sep 04Recent updates
Here's Why Sawai Group Holdings (TSE:4887) Has Caught The Eye Of Investors
Dec 20Here's Why Sawai Group Holdings (TSE:4887) Has A Meaningful Debt Burden
Nov 30Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?
Sep 04Sawai Group Holdings Co., Ltd. (TSE:4887) Shares Could Be 47% Below Their Intrinsic Value Estimate
Aug 12Sawai Group Holdings (TSE:4887) Has A Pretty Healthy Balance Sheet
Jul 27Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?
May 28Is There An Opportunity With Sawai Group Holdings Co., Ltd.'s (TSE:4887) 41% Undervaluation?
Apr 22Is Sawai Group Holdings (TSE:4887) A Risky Investment?
Mar 06Shareholder Returns
| 4887 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -1.4% | 0.9% | 2.1% |
| 1Y | 23.9% | 11.8% | 15.6% |
Return vs Industry: 4887 exceeded the JP Pharmaceuticals industry which returned 12.8% over the past year.
Return vs Market: 4887 exceeded the JP Market which returned 16.3% over the past year.
Price Volatility
| 4887 volatility | |
|---|---|
| 4887 Average Weekly Movement | 4.2% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JP Market | 7.2% |
| 10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 4887 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4887's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1929 | 3,482 | Mitsuo Sawai | www.sawaigroup.holdings |
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and anus, chemotherapeutic and antineoplastic agents, respiratory system, etc., as well as vitamin preparations. It sells its generic drugs through distributors, wholesalers, and retailers in Japan and the United States.
Sawai Group Holdings Co., Ltd. Fundamentals Summary
| 4887 fundamental statistics | |
|---|---|
| Market cap | JP¥262.37b |
| Earnings (TTM) | JP¥16.55b |
| Revenue (TTM) | JP¥177.34b |
15.9x
P/E Ratio1.5x
P/S RatioIs 4887 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4887 income statement (TTM) | |
|---|---|
| Revenue | JP¥177.34b |
| Cost of Revenue | JP¥122.84b |
| Gross Profit | JP¥54.50b |
| Other Expenses | JP¥37.94b |
| Earnings | JP¥16.55b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 135.70 |
| Gross Margin | 30.73% |
| Net Profit Margin | 9.33% |
| Debt/Equity Ratio | 46.4% |
How did 4887 perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield38%
Payout RatioDoes 4887 pay a reliable dividends?
See 4887 dividend history and benchmarks| Sawai Group Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 26 2025 |
| Days until Ex dividend | 87 days |
| Days until Dividend pay date | 177 days |
Does 4887 pay a reliable dividends?
See 4887 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 06:16 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sawai Group Holdings Co., Ltd. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Ritsuo Watanabe | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |